3 systems, 1 pipeline
An integrated platform to cut the time and cost of translating biomarkers into clinical tests by 10×.
Clinical lab
Streamlined infrastructure for agile and efficient operations
High-quality biorepository
Large, well-controlled, and characterized cohorts
Clinical bioinformatics
Clinical support and real-world evidence generation
Greater clarity for complex post-infection illness
Infection-associated chronic conditions are a group of complex and poorly understood illnesses that can persist or emerge following an infection. While their full burden remains unclear, Long COVID alone affects approximately 17 million Americans. For many, it means years of symptoms that disrupt work, family life, and everyday routines.
Despite its magnitude, there are still no validated lab tests for Long COVID or many other similar conditions. In their absence, without objective diagnostics, clinicians must rely on diagnosis by exclusion, a process that can require months of appointments, imaging, and specialist visits, and cost thousands of dollars. And even after diagnosis, care is frequently guided by symptoms alone, with few objective markers to personalize treatment.
Our goal is to develop robust, clinically practical lab tests that support diagnosis and help guide care for these conditions, starting with Long COVID. These tools can reduce diagnostic delays, enable more effective and consistent treatment, and accelerate the development of new therapies.
